Pfizer and Astellas refused to conduct further research of Xtandi
Pfizer and its partner Astellas refused to test breast cancer…
UDG invests in the world trends of the pharmaceutical market
A specialist in rare disease drug launches, Cambridge BioMarketing…
Great changes in GSK
Great changes are coming in GlaxoSmithKline. The reason for this…
GSK successfully develops Benlysta
GlaxoSmithKline hopes to get its new Benlysta formula under lupus…
Vice Premier touched upon the problem of oncology in Russia
The death rate from cancer in Russia is higher than in advanced…
New medicines labeling law
On Government of the Russian Federation website information,…